HMP Market Access Insights

With the presidential and Senate races decided, the House of Representatives is the last piece of the puzzle—and it’s coming down to the wire. Control remains undecided as we wait on key races, especially in states with significant mail-in voting like California, Oregon, and Washington. This outcome will shape the legislative landscape, especially for health care. A narrow majority, regardless of which party wins, means individual representatives could have a huge influence on passing or blocking key policies. Health care reform, Medicare drug pricing, and ACA provisions are just a few of the issues hanging in the balance. We’re looking at a historic moment: one of the slimmest majorities in recent memory, which could set a precedent for future sessions of Congress. Check out our latest Behind the Bill post for more ⬇ #BehindtheBill #HMPMarketAccessInsights #Election2024 #HealthcarePolicy

Our 2024 Community Oncology Trend Report Executive Summary offers a concise breakdown of the essential data and trends you need to shape impactful strategies. Stay ahead with insights that matter—download your free copy today! https://lnkd.in/e8KE8n_f #HMPMarketAccessInsights #Oncology #CommunityOncology #HealthcareInsights #MarketAccess #TrendReport #HMPGlobal

As we near Election Day, the Supreme Court faces key decisions that will influence election administration for years to come. Their rulings in RNC v. Genser and Beals v. Virginia Coalition for Immigrant Rights could reshape the relationship between state and federal courts, impacting both the democratic process and broader policy issues like healthcare. Check out our latest Behind the Bill post for more ⬇ #BehindtheBill #HMPMarketAccessInsights #Election2024 #SupremeCourt #HealthcarePolicy

As the Inflation Reduction Act (IRA) rolls out new Maximum Fair Pricing (MFP) rules, integrated delivery networks (IDNs) and manufacturers are confronted with the complexities of managing overlapping 340B discounts and MFPs. Get up to speed on the key issues impacting providers and manufacturers. Read the blog now: https://lnkd.in/egDRZPMt #HMPMarketAccessInsights #Healthcare #MarketAccess #340B #InflationReductionAct #IntegratedDeliveryNetworks #Manufacturers #Oncology 

Community oncology is rising to meet the demand for bispecific therapies, though many still rely on hospital partnerships to manage advanced treatments. Did you know 85% of sophisticated practices are engaged in CAR-T and bispecific therapies? Discover how these practices are shaping patient access and care strategies. 🔗 Read more now: https://lnkd.in/eqRdnKxY #HMPMarketAccessInsights #ClinicalPathwaysCongress #DisruptCancerCare #BispecificTherapies #CommunityOncology #PatientAccess 

With the 2024 elections just 13 days away, everyone has one question: What happens next? From potential changes to the ACA to the unpredictable polling data, this election could reshape how Americans access care. Navigating this evolving landscape requires staying informed and adaptable. Dive deeper into what this means for the future of healthcare in our latest Behind the Bill ⬇ #HMPMarketAccessInsights #HealthPolicy #2024Elections #BehindTheBill #HealthcareReform

The second application cycle of the Enhancing Oncology Model (EOM) has officially closed, bringing significant updates that will impact community oncology practices across the country. Whether you’re directly involved in oncology or watching from the sidelines, these shifts are worth keeping an eye on: ➡ New payment structures are aimed at improving financial viability for practices ➡Enhanced care coordination is expected to lead to better patient outcomes ➡More practices are joining the model, but is true transformation in sight? Learn more about the current impact of EOM here: https://lnkd.in/eXrr6qi6 #HMPMarketAccessInsights #CommunityOncology #EOM

The IRA drug negotiations will cut provider Medicare buy-and-bill revenues by over 40% for select negotiated drugs. This major shift could impact the bottom line for many providers, particularly in oncology. Are you prepared for this change?     Get the insights you need to drive your strategy with our latest 2024 Landscape Report. 🔗  https://lnkd.in/eSEA5CAK    #HMPMarketAccessInsights #MAIReports #Healthcare #Oncology #IRA #Medicare #MarketAccess #PharmaStrategy #RevenueImpact 

In this week's #BehindtheBill, we explore why even some of its most vocal supporters have moved on from Medicare for All and why we should focus on more practical health care reforms. Check it out now ⬇ #HMPMarketAccessInsights #BehindtheBill #MedicareforAll #OncologyAccess #HealthCareInnovation #HealthCareStrategy #Medicare #HealthPolicy #MarketAccess

Next week, Lee Blansett, Chris Van Denburg and Ramon Auciello will be attending the Association for Value-Based Cancer Care (AVBCC) event in NYC. If you're attending and want to learn how we can support your oncology market access strategies, let's connect. Reach out to get on their schedule — they'd love to meet with you! #HMPMarketAccessInsights #Oncology #MarketAccess #AVBCC #CancerCare #HealthCareInnovation #ValueBasedCare